BRPI0814602A2 - Aperfeiçoamentos relacionados a formulações de comprimido anti-hiv - Google Patents

Aperfeiçoamentos relacionados a formulações de comprimido anti-hiv

Info

Publication number
BRPI0814602A2
BRPI0814602A2 BRPI0814602-0A2A BRPI0814602A BRPI0814602A2 BR PI0814602 A2 BRPI0814602 A2 BR PI0814602A2 BR PI0814602 A BRPI0814602 A BR PI0814602A BR PI0814602 A2 BRPI0814602 A2 BR PI0814602A2
Authority
BR
Brazil
Prior art keywords
hiv
improvements relating
pill formulations
pill
formulations
Prior art date
Application number
BRPI0814602-0A2A
Other languages
English (en)
Inventor
Guido Franciscus Smans
Eugeen Maria Jozef Jans
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of BRPI0814602A2 publication Critical patent/BRPI0814602A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0814602-0A2A 2007-07-25 2008-07-25 Aperfeiçoamentos relacionados a formulações de comprimido anti-hiv BRPI0814602A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07113104 2007-07-25
PCT/EP2008/059802 WO2009013356A2 (en) 2007-07-25 2008-07-25 Anti-hiv tablet formulations comprising darunavir

Publications (1)

Publication Number Publication Date
BRPI0814602A2 true BRPI0814602A2 (pt) 2015-01-27

Family

ID=38666812

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0814602-0A2A BRPI0814602A2 (pt) 2007-07-25 2008-07-25 Aperfeiçoamentos relacionados a formulações de comprimido anti-hiv

Country Status (12)

Country Link
US (1) US20100189783A1 (pt)
EP (1) EP2182926A2 (pt)
JP (1) JP2010534222A (pt)
CN (1) CN101820865A (pt)
AR (1) AR069539A1 (pt)
AU (1) AU2008278974A1 (pt)
BR (1) BRPI0814602A2 (pt)
CA (1) CA2693235A1 (pt)
IL (1) IL202651A0 (pt)
NZ (1) NZ600472A (pt)
RU (1) RU2010106616A (pt)
WO (1) WO2009013356A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011051978A2 (en) * 2009-10-30 2011-05-05 Lupin Limited A novel process for preparation of darunavir and darunavir ethanolate of fine particle size
US20130195978A1 (en) * 2010-05-10 2013-08-01 Hetero Research Foundation Darunavir Compositions
SI2729128T1 (sl) * 2011-07-07 2016-11-30 Janssen Sciences Ireland Uc Formulacije darunavirja
EP2729130B1 (en) 2011-07-07 2017-09-06 Janssen Sciences Ireland UC Darunavir combination formulations
ES2952878T3 (es) 2016-08-08 2023-11-06 Hetero Labs Ltd Una composición antirretroviral multiclase
BR112019002132A2 (pt) 2016-08-08 2019-05-14 Hetero Labs Limited composições anti-retrovirais
CN119700779B (zh) * 2024-11-28 2025-11-04 安徽贝克生物制药有限公司 一种达芦那韦和考比司他复合片剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733578A (en) * 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
AR053845A1 (es) * 2005-04-15 2007-05-23 Tibotec Pharm Ltd 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450
WO2007017249A1 (en) * 2005-08-08 2007-02-15 Abbott Gmbh & Co. Kg Dosage forms with improved bioavailability
WO2007054085A2 (de) * 2005-11-11 2007-05-18 Ljubicic, Mijo Antivirales mittel umfassend tribomechanisch aktiviertes zeolith (tmaz), propolis und kolostrum

Also Published As

Publication number Publication date
RU2010106616A (ru) 2011-08-27
AU2008278974A1 (en) 2009-01-29
CA2693235A1 (en) 2009-01-29
NZ600472A (en) 2013-09-27
EP2182926A2 (en) 2010-05-12
CN101820865A (zh) 2010-09-01
WO2009013356A2 (en) 2009-01-29
JP2010534222A (ja) 2010-11-04
IL202651A0 (en) 2010-06-30
AR069539A1 (es) 2010-02-03
US20100189783A1 (en) 2010-07-29
WO2009013356A3 (en) 2009-04-02

Similar Documents

Publication Publication Date Title
BRPI0806543A2 (pt) Composições de comprimido em comprimido
BRPI0808889A2 (pt) Comprimido desintegrante oral
BRPI0820381A2 (pt) Formulações farmacêuticas
DK3061445T3 (da) Højkoncentrerede farmaceutiske formuleringer
EP2251005A4 (en) Orally disintegrating tablets
ZA200900030B (en) Improvements relating to pharmaceutical compositions
DK3492069T3 (da) Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
PT2455477E (pt) Plantas resistentes a doenças
DK2131813T3 (da) Topiske, farmaceutiske formuleringer
PT2180901E (pt) Purificação de conjugados utilizando hidroxiapatite
EP2451274A4 (en) Pharmaceutical compositions
EP2419097A4 (en) PHARMACEUTICAL COMPOSITIONS
DK2114143T3 (da) Flydende sulfonylurea-herbicidformuleringer
BRPI0814188A2 (pt) Formulações
BRPI0912056A2 (pt) "um fecho"
EP2362725A4 (en) ANTIVIRES SUPPLEMENT FORMULATIONS
DK2194959T3 (da) Skummedygtig mundplejetilberedning
BRPI0817260A2 (pt) Ácidos nucleicos de ligação a c5a
BRPI0814602A2 (pt) Aperfeiçoamentos relacionados a formulações de comprimido anti-hiv
BRPI0820198A2 (pt) composições farmacêuticas
EP1931346A4 (en) TRAZODON COMPOSITION FOR ONE DAILY ADMINISTRATION
ZA201000260B (en) Improvements relating to perfumes
BRPI0806938A2 (pt) Composição farmacêutica contedo um derivado de camptotecina
FI20080348A0 (fi) Uudenlainen farmaseuttinen formulaatio
BRPI0809936A2 (pt) Composto sulfonado de açúcar e uso do mesmo como medicamento

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.